{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:44:15Z","timestamp":1792658655080,"version":"4.5.0"},"reference-count":49,"publisher":"American Chemical Society (ACS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Chem. Biol."],"published-print":{"date-parts":[[2016,5,20]]},"DOI":"10.1021\/acschembio.5b01063","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T19:05:14Z","timestamp":1455131114000},"page":"1245-1254","source":"Crossref","is-referenced-by-count":102,"title":["Chemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors"],"prefix":"10.1021","volume":"11","author":[{"given":"Susan","family":"Klaeger","sequence":"first","affiliation":[{"name":"Chair\rof Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany"},{"name":"German Cancer Consortium (DKTK), Munich, Germany"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Gohlke","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Structural\rBioinformatics Group, Charit\u00e9-Universit\u00e4tsmedizin, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Perrin","sequence":"additional","affiliation":[{"name":"Cellzome GmbH, a GSK company, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department\rof Nanoparticle Translational Research, Tokyo Medical University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Heinzlmeir","sequence":"additional","affiliation":[{"name":"Chair\rof Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany"},{"name":"German Cancer Consortium (DKTK), Munich, Germany"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Helm","sequence":"additional","affiliation":[{"name":"Chair\rof Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichao","family":"Qiao","sequence":"additional","affiliation":[{"name":"Chair\rof Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Bergamini","sequence":"additional","affiliation":[{"name":"Cellzome GmbH, a GSK company, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[{"name":"Department\rof Nanoparticle Translational Research, Tokyo Medical University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail M","family":"Savitski","sequence":"additional","affiliation":[{"name":"Cellzome GmbH, a GSK company, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bantscheff","sequence":"additional","affiliation":[{"name":"Cellzome GmbH, a GSK company, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"M\u00e9dard","sequence":"additional","affiliation":[{"name":"Chair\rof Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Preissner","sequence":"additional","affiliation":[{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Structural\rBioinformatics Group, Charit\u00e9-Universit\u00e4tsmedizin, Berlin, Germany"},{"name":"German Cancer Consortium (DKTK), Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Kuster","sequence":"additional","affiliation":[{"name":"Chair\rof Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany"},{"name":"German Cancer Consortium (DKTK), Munich, Germany"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"},{"name":"Bavarian\rBiomolecular Mass Spectrometry Center, Technical University of Munich, Freising, Germany"},{"name":"Center for Integrated Protein Science Munich (CIPSM), Freising, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd773"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1075762"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1021\/cb300610s"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.04.005"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1990"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1358"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2017"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-337-0_11"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2012.01.002"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1328"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/pr5012608"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-102061"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.130"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1038\/nature13194"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255784"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1038\/nature09454"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103782"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002011"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2015.2628"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12119"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1113752"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08577.x"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1021\/pr301073j"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233606"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910230202"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/280164a0"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.24.4998"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1038\/84152"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1124\/mol.113.087940"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108189"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi029"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-19"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0333"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt435"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.115.228130"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(92)85108-7"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.4145"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.8487"},{"key":"ref39\/cit39","volume":"49","author":"Ou S.","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref40\/cit40","unstructured":"Pfizer. Inlyta (axitinib) oral tablets: US prescribing information(revised: 8\/2014). www.inlyta.com."},{"key":"ref41\/cit41","unstructured":"Novartis. ( (2007) Tasigna (nilotinib) Capsules for oral use: Highlights of Prescribing Information (revised 1\/2015)."},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1978"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.6.443"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1997.tb08549.x"},{"key":"ref45\/cit45","first-page":"153","volume":"67","author":"Yamamoto M.","year":"2013","journal-title":"Acta Med. Okayama"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1511"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1021\/pr101065j"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M113.031591"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0897"}],"container-title":["ACS Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acschembio.5b01063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T07:56:55Z","timestamp":1682236615000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acschembio.5b01063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,25]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,20]]}},"alternative-id":["10.1021\/acschembio.5b01063"],"URL":"https:\/\/doi.org\/10.1021\/acschembio.5b01063","relation":{},"ISSN":["1554-8929","1554-8937"],"issn-type":[{"value":"1554-8929","type":"print"},{"value":"1554-8937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,25]]}}}